Evidence map›Paper›PMID 34532356›Full record

ArticleAnnals of translational medicine2021

Shock in China 2018 (SIC-study): a cross-sectional survey.

Longxiang Su, Xudong Ma, Xi Rui, Huaiwu He, Ye Wang, Guangliang Shan, Yan Kang, You Shang, Ruiqiang Zheng, Shusheng Li and 16 more

Erratum issuedOpen access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Incidence of mortality and predictors among patients with shock managed in the emergency room of a tertiary hospital in Ethiopia.African journal of emergency medicine : Revue africaine de la medecine d'urgence · 2025
    Article
  2. Shock epidemiology and outcomes among internal medicine patients.The Southern African journal of critical care : the official journal of the Critical Care Society · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 11 institutions in 1 country.

Longxiang SuDepartment of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Xudong MaDepartment of Medical Administration, National Health Commission of the People's Republic of China, Beijing, China.
Xi RuiDepartment of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Huaiwu HeDepartment of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Ye WangDepartment of Epidemiology and Biostatistics, Institute of Basic Medicine Sciences, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Guangliang ShanDepartment of Epidemiology and Biostatistics, Institute of Basic Medicine Sciences, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Yan KangDepartment of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
You ShangDepartment of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ruiqiang ZhengDepartment of Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou, China.
Shusheng LiDepartment of Critical Care Medicine, Tongji Hospital affiliated to Tongji Medical College Huazhong University of Science and Technology, Wuhan, China.
Qingyuan ZhanDepartment of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China.
Renyu DingDepartment of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China.
Yongjie YinDepartment of Emergency and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China.
Li JiangDepartment of Critical Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Lina ZhangDepartment of Critical Care Medicine, Xiangya Hospital, Changsha, China.
Qinggang GeDepartment of Critical Care Medicine, Zhejiang Hospital, Hangzhou, China.
Liu ZhangDepartment of Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Junyu LuDepartment of Critical Care Medicine, Peking University People's Hospital, Beijing, China.
Linjun WanDepartment of Critical Care Medicine, Guangxi Medical University Affiliated Hospital, Nanning, China.
Jing YanDepartment of Critical Care Medicine, Zhejiang Medical University Affiliated Hospital, Hangzhou, China.
Dawei LiuDepartment of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Yun LongDepartment of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Xiangdong GuanDepartment of Critical Care Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Dechang ChenDepartment of Critical Care Medicine, Ruijin Hospital affiliated to Medical College of Shanghai Jiaotong University, Shanghai, China.
Xiang ZhouDepartment of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Shuyang ZhangDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Peking Union Medical College Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNChina-Japan Friendship Hospital · CNChina Medical University · CNHuazhong University of Science and Technology · CNNorthern Jiangsu People's Hospital · CNPeking University Third Hospital · CNSecond Affiliated Hospital of Jilin University · CNTongji Hospital · CNWest China Hospital of Sichuan University · CNZhejiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShock is a critical illness that seriously threatens the lives of patients. This study explains the epidemiology of shock, mortality of shock, and identify factors that related to hospital death.

methodsThis is a multi-centre cross-sectional survey, which included 1,064 tertiary hospitals in 31 provinces, municipalities, and autonomous regions across China mainland. Totally 289,428 patients who diagnosed with shock based on the ICD-10 abstracted from the Hospital Quality Monitoring System (HQMS) in 2018, a national database administrated by National Health Commission of the PRC.

resultsPatients diagnosed with shock were screened and classified according to the type of shock. Regression analysis was used to identify factors that related to death. A total of 79,668,156 medical records were included in HQMS in 2018, from which a total of 289,428 records with shock were identified. Hypovolemic shock occurred in 128,436 cases (44.38%), septic shock occurred in 121,543 cases (41.99%), cardiogenic shock occurred in 44,597 cases (15.41), and obstructive shock occurred in 3,168 cases (1.09%). Of these, 8,147 cases (2.81%) had mixed shock, which means had two or more types of shock. For all the shock cases, the top three frequent concomitant diseases recorded were circulatory system diseases (55.22%), digestive system diseases (53.64%), and respiratory system diseases (53.31%). Of the four types of shock, cases with cardiogenic shock had the highest in-hospital mortality (31.6%), followed by those with obstructive shock (25.2%), septic shock (22.9%), and hypovolemic shock (15.5%). Interestingly, the combination of shock and malignant tumors is one of the major factors that related to hospital deaths.

conclusionsShock is a serious disease with a high fatality rate and huge clinical costs. According to this epidemiological survey of shock in China 2018, we should clarify the factors related to the hospital death in shock cases.

Indexed as

epidemiologyHospital Quality Monitoring System (HQMS)outcomerisk factorShock

Identifiers

PMID34532356
PMCPMC8421935
OpenAlexW3188513876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.